CDKN1C
関連文献

“Genes associated with tumor suppression and growth control in the human nervous system”. Cancer and Metastasis Reviews 10 (4):  281–7. (Dec 1991). doi:10.1007/BF00554790. PMID 1786629.
“Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution”. Genes & Development 9 (6):  639–49. (Mar 1995). doi:10.1101/gad.9.6.639. PMID 7729683.
“p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene”. Genes & Development 9 (6):  650–62. (Mar 1995). doi:10.1101/gad.9.6.650. PMID 7729684.
“Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15”. Proceedings of the National Academy of Sciences of the United States of America 93 (7):  3026–30. (Apr 1996). Bibcode: 1996PNAS...93.3026M. doi:10.1073/pnas.93.7.3026. PMC 39755. PMID 8610162. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC39755/.
“Genomic organization of the human p57KIP2 gene and its analysis in the G401 Wilms' tumor assay”. Cancer Research 56 (6):  1214–8. (Mar 1996). PMID 8640800.
“Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis”. Human Genetics 97 (5):  625–31. (May 1996). doi:10.1007/BF02281873. PMID 8655143.
“An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome”. Nature Genetics 14 (2):  171–3. (Oct 1996). doi:10.1038/ng1096-171. PMID 8841187.
“Isolation of a novel GPI-anchored gene specifically regulated by p53; correlation between its expression and anti-cancer drug sensitivity”. Oncogene 13 (9):  1965–70. (Nov 1996). PMID 8934543.
“New functional activities for the p21 family of CDK inhibitors”. Genes & Development 11 (7):  847–62. (Apr 1997). doi:10.1101/gad.11.7.847. PMID 9106657.
“Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen”. Proceedings of the National Academy of Sciences of the United States of America 95 (4):  1392–7. (Feb 1998). Bibcode: 1998PNAS...95.1392W. doi:10.1073/pnas.95.4.1392. PMC 19016. PMID 9465025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC19016/.
“Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome”. Human Genetics 104 (3):  205–10. (Mar 1999). doi:10.1007/s004390050937. PMID 10323243.
“Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation”. Journal of Medical Genetics 36 (7):  518–23. (Jul 1999). doi:10.1136/jmg.36.7.518. PMC 1734395. PMID 10424811. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1734395/.
“Stabilization of MyoD by direct binding to p57(Kip2)”. The Journal of Biological Chemistry 275 (25):  18767–76. (Jun 2000). doi:10.1074/jbc.M907412199. PMID 10764802.
“Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors”. Experimental Hematology 29 (4):  490–8. (Apr 2001). doi:10.1016/S0301-472X(01)00619-1. PMID 11301189.
“Identification and functional characterization of an intragenic DNA binding site for the spumaretroviral trans-activator in the human p57Kip2 gene”. The Journal of Biological Chemistry 277 (14):  12032–9. (Apr 2002). doi:10.1074/jbc.M108747200. PMID 11815601.
“Induction of p57(KIP2) expression by p73beta”. Proceedings of the National Academy of Sciences of the United States of America 99 (6):  3529–34. (Mar 2002). Bibcode: 2002PNAS...99.3529B. doi:10.1073/pnas.062491899. PMC 122557. PMID 11891335. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC122557/.
“Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues”. International Journal of Molecular Medicine 9 (4):  373–6. (Apr 2002). doi:10.3892/ijmm.9.4.373. PMID 11891530.
“Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors”. Oncogene 21 (17):  2741–9. (Apr 2002). doi:10.1038/sj.onc.1205376. PMID 11965547.
“Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype”. Blood 100 (7):  2572–7. (Oct 2002). doi:10.1182/blood-2001-11-0026. PMID 12239171.